Published date: 21 June 2019

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 11 February 2019

Contract summary

Industry

  • Peptones and protein substances - 24956000

  • General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents - 33650000

Location of contract

Any region

Value of contract

£15,000

Procurement reference

tender_198898/778143

Published date

21 June 2019

Closing date

11 February 2019

Contract start date

14 February 2019

Contract end date

31 March 2020

Contract type

Supply contract

Procedure type

Open procedure (below threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements below the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

Public Health England (PHE) awarded the contract for the Borrelia miyamotoi antigens (GlpQ and Vlp15/16) for its South West Regional Laboratory to The Native Antigen Company.

If you feel that you can meet the above requirements or would like more information, then please access the tender documents via link: https://phe.bravosolution.co.uk/

More information

Previous notice about this procurement

Provision of GlpQ and Vlp15/16 Borrelia miyamotoi antigens

  • Opportunity
  • Published 30 January 2019, last edited 30 January 2019

Links

Award information

Awarded date

11 February 2019

Contract start date

14 February 2019

Contract end date

31 March 2020

Total value of contract

£15,000

This contract was awarded to 1 supplier.

The Native Antigen Company Limited

Address

Building b Langford Locks Kidlington Oxfordshire OX5 1LH

Reference

Companies House number: 07386339

Supplier is SME?

Yes

Supplier is VCSE?

No

About the buyer

Address

133-155 Waterloo Road
London
SE1 8UG
England

Email

anna.gibson@phe.gov.uk